The new study involved more than 400 people with cancer who were treated at Memorial Sloan Kettering Cancer Center (MSKCC). Each received an mRNA COVID-19 vaccine before or after treatment with a type of immunotherapy drug known as an immune checkpoint inhibitor.An analysis of the patients’ medical records revealed no evidence that mRNA COVID-19 vaccination had increased the type, frequency, or severity of immune-related side effectsExit Disclaimer, such as inflammation in the lungs or colon, researchers found.
Source: COVID-19 Vaccines Safe with Immune Checkpoint Inhibitors – NCI
